CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis

被引：59
|
作者：
Narikawa, K
Misu, T
Fujihara, K
Nakashima, I
Sato, S
Itoyama, Y
机构：
[1] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan
[2] Kohnan Hosp, Dept Neurol, Sendai, Miyagi 9828523, Japan
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2004年 / 149卷 / 1-2期
关键词：
relapsing neuromyelitis optica; multiple sclerosis; chemokine;
D O I：
10.1016/j.jneuroim.2003.12.010
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The pathogenesis of relapsing neuromyelitis optica (RNMO) remains unknown. We, for the first time, studied the levels of four chemokines in the cerebrospinal fluid in RNMO with ELISA and compared the data with those in multiple sclerosis (MS) and control. CXCL10/IP-10 and CCL17/TARC were significantly elevated in both RNMO and MS. Conversely, CCL2/MCP-1 was significantly lower in MS, but not in RNMO, than in control. CCL11/Eotaxin was not different between groups. None of the four chemokines studied was significantly different between RNMO and MS. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码：182 / 186
页数：5
相关论文
共 50 条
  • [31] The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder
    Cho, Eun Bin
    Jung, Se Young
    Jung, Jin-Hyung
    Yeo, Yohwan
    Kim, Hee Jin
    Han, Kyungdo
    Shin, Dong Wook
    Min, Ju-Hong
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [32] Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis
    Vanotti, Sandra
    Valeria Cores, Evangelina
    Eizaguirre, Barbara
    Melamud, Luciana
    Rey, Raul
    Villa, Andres
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (06) : 357 - 361
  • [33] Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis
    Tong, Yanping
    Liu, Jie
    Yang, Tao
    Kang, Yuezhi
    Wang, Jingwen
    Zhao, Tianyou
    Cheng, Cuicui
    Fan, Yongping
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 25 : 61 - 65
  • [34] Treatment Options in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
    Rommer, Paulus
    Zettl, Uwe K.
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (06) : 428 - 436
  • [35] Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients
    Long, Youming
    Gao, Cong
    Qiu, Wei
    Hu, Xueqiang
    Peng, Fuhua
    Lu, Zhengqi
    NEUROLOGICAL RESEARCH, 2013, 35 (09) : 922 - 929
  • [36] Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family
    Gelibter, S.
    Mazzi, B.
    Tassara, M.
    Colombo, B.
    Guerrieri, S.
    Giordano, A.
    Preziosa, P.
    Comola, M.
    Esposito, F.
    Martinelli, V.
    Rocca, M. A.
    Comi, G.
    Leocani, L.
    Martinelli-Boneschi, F.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 25 : 73 - 76
  • [37] Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica
    Nakano, Hitoshi
    Tanaka, Masami
    Kinoshita, Masako
    Tahara, Masayuki
    Matsui, Masaru
    Tanaka, Keiko
    Konishi, Tetsuro
    EPILEPSY RESEARCH, 2013, 104 (1-2) : 175 - 180
  • [38] Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis
    Simon, K. C.
    Schmidt, H.
    Loud, S.
    Ascherio, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 703 - 709
  • [39] The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica
    Moayednia, Milad
    Dehghani, Leila
    Safi, Amir
    Shaygannejad, Vahid
    Sohrabi, Karim
    Rezvani, Majid
    Soghrati, Mojgan
    Aboutalebi, Mohammad Mahdi
    Barzegar, Mahdi
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (02) : 199 - 204
  • [40] Comparison of olfactory function between neuromyelitis optica and multiple sclerosis
    Li, Li-Min
    Guo, Hui-Yue
    Zhao, Ning
    Zhang, Lin-Jie
    Zhang, Ningnannan
    Liu, Jingchun
    Yang, Li
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2018, 128 (08) : 772 - 777
12345